tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Personal Finance CenterMortgagesLoansInvesting & RetirementSpending & Savings
Calculators
401k Retirement CalculatorMortgage Calculator
Popular
Compound Interest CalculatorDollar Cost Averaging
New
Student Loan CalculatorAuto Loan Calculator
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

CHRS Stock Latest News

Biotech Alert: Searches spiking for these stocks today
The FlyBiotech Alert: Searches spiking for these stocks today
13d ago
EBS
ARCT
Coherus Biosciences price target lowered to $8 from $9 at Baird
PremiumThe Fly
Coherus Biosciences price target lowered to $8 from $9 at Baird
17d ago
CHRS
Coherus BioSciences Announces Divestiture of YUSIMRY (adalimumab-aqvh) in a $40 Million Upfront All Cash Transaction
PremiumPress Releases
Coherus BioSciences Announces Divestiture of YUSIMRY (adalimumab-aqvh) in a $40 Million Upfront All Cash Transaction
21d ago
CHRS
Coherus Biosciences announces divestiture of YUSIMRY in $40M transaction
PremiumThe Fly
Coherus Biosciences announces divestiture of YUSIMRY in $40M transaction
21d ago
CHRS
Coherus Biosciences Appoints Rita Karachun to Board
PremiumCompany Announcements
Coherus Biosciences Appoints Rita Karachun to Board
1M ago
8K
CHRS
Coherus Biosciences appoints Karachun to board of directors
PremiumThe FlyCoherus Biosciences appoints Karachun to board of directors
1M ago
MRK
CHRS
Coherus BioSciences Appoints Rita Karachun, CPA, CGMA to its Board of Directors
PremiumPress Releases
Coherus BioSciences Appoints Rita Karachun, CPA, CGMA to its Board of Directors
1M ago
CHRS
Coherus Biosciences presents preliminary Phase I results of CHS-114
PremiumThe Fly
Coherus Biosciences presents preliminary Phase I results of CHS-114
2M ago
CHRS
Coherus Presents Preliminary Results from Phase I Dose Escalation Study of its Anti-chemokine receptor 8 (CCR8) Antibody, CHS-114, at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
PremiumPress Releases
Coherus Presents Preliminary Results from Phase I Dose Escalation Study of its Anti-chemokine receptor 8 (CCR8) Antibody, CHS-114, at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
2M ago
CHRS
Coherus Management to Present at the TD Cowen 5th Annual Oncology Innovation Virtual Summit: Insights for ASCO & EHA
PremiumPress Releases
Coherus Management to Present at the TD Cowen 5th Annual Oncology Innovation Virtual Summit: Insights for ASCO & EHA
2M ago
CHRS
Coherus Biosciences price target raised to $12 from $11 at H.C. Wainwright
PremiumThe Fly
Coherus Biosciences price target raised to $12 from $11 at H.C. Wainwright
2M ago
CHRS
Coherus Biosciences reports Q1 EPS (32c), consensus (24c)
PremiumThe Fly
Coherus Biosciences reports Q1 EPS (32c), consensus (24c)
2M ago
CHRS
Coherus Biosciences announces full repayment of $75M term loan
PremiumThe FlyCoherus Biosciences announces full repayment of $75M term loan
2M ago
CHRS
Coherus Biosciences Embarks on Strategic Financial Restructuring
PremiumCompany Announcements
Coherus Biosciences Embarks on Strategic Financial Restructuring
2M ago
8K
CHRS
Coherus Biosciences announces clinical collaboration with CRI
PremiumThe Fly
Coherus Biosciences announces clinical collaboration with CRI
2M ago
CHRS
Coherus Announces Clinical Collaboration with the Cancer Research Institute for a Novel Combination Evaluating LOQTORZI® (toripalimab-tpzi) with ENB Therapeutics’ ENB-003 for the Treatment of Ovarian Cancer
PremiumPress Releases
Coherus Announces Clinical Collaboration with the Cancer Research Institute for a Novel Combination Evaluating LOQTORZI® (toripalimab-tpzi) with ENB Therapeutics’ ENB-003 for the Treatment of Ovarian Cancer
2M ago
CHRS
CHRS Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-Earnings
CHRS Earnings Report this Week: Is It a Buy, Ahead of Earnings?
2M ago
CHRS
Coherus to Report First Quarter 2024 Financial Results on May 9, 2024
PremiumPress Releases
Coherus to Report First Quarter 2024 Financial Results on May 9, 2024
3M ago
CHRS
Coherus Announces Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
PremiumPress Releases
Coherus Announces Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
3M ago
CHRS
Coherus data show CHS-1000 acts to reverse myeloid suppression
PremiumThe FlyCoherus data show CHS-1000 acts to reverse myeloid suppression
3M ago
CHRS
Coherus Presents Preclinical Data for CHS-1000, a Novel Anti-ILT4 Antibody, at the 2024 AACR Annual Meeting
PremiumPress Releases
Coherus Presents Preclinical Data for CHS-1000, a Novel Anti-ILT4 Antibody, at the 2024 AACR Annual Meeting
3M ago
CHRS
Coherus Biosciences price target lowered to $11 from $13 at H.C. Wainwright
PremiumThe Fly
Coherus Biosciences price target lowered to $11 from $13 at H.C. Wainwright
4M ago
CHRS

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >